You are here

AstraZeneca

ASCO17: AstraZeneca pumps up expectations on near-term cancer drug wins, looking to shed a rep for failure

Endpoints

Tue, 06/6/17 - 09:44 am

AstraZeneca's Lynparza Slows Breast Cancer Caused By BRCA Mutations By 42%

Forbes

Sun, 06/4/17 - 11:53 am

BRCA-mutant breast cancer

EMA recommends 11 drugs for approval in May meeting

BioPharma Dive

Thu, 05/25/17 - 09:26 am

AZ's Bydureon cleared a heart safety test, but didn't cut risks. Can it still vie with Novo?

Fierce Pharma

Tue, 05/23/17 - 08:17 am

AstraZeneca's new benralizumab helps severe asthma patients cut back on steroids

Fierce Pharma

Mon, 05/22/17 - 07:44 pm

AZ's controversial castoffs continue with $300M heart-med sale to Recordati

Fierce Pharma

Mon, 05/22/17 - 09:54 am

AstraZeneca throws a monkey wrench in new GSK CEO’s first hiring decision, suing Luke Miels

Endpoints

Tue, 05/16/17 - 11:31 am

AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next

Forbes

Fri, 05/12/17 - 11:44 am

AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC

Endpoints

Fri, 05/12/17 - 09:40 am

clinical trials

non-small cell lung cancer

AstraZeneca’s PhIII bid on asthma drug tralokinumab flops, and that’s no surprise

Endpoints

Wed, 05/10/17 - 09:38 am

clinical trials

Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town

Fierce Pharma

Wed, 05/10/17 - 09:31 am

AstraZeneca's New Drug: Too Little, Too Late?

Seeking Alpha

Mon, 05/8/17 - 09:51 pm

Pieris, AstraZeneca ink $45m deal for inhaled respiratory drugs

Drug Delivery Business News

Thu, 05/4/17 - 09:43 am

AstraZeneca Tops Earnings Estimate, But Crestor and Onglyza Sales Slow

TheStreet.com

Thu, 04/27/17 - 09:23 am

Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi

BioPharma Dive

Wed, 04/26/17 - 09:29 pm

Bristol-Myers Squibb

What Analysts Predict for AstraZeneca’s 1Q17 Earnings

Market Realist

Wed, 04/26/17 - 10:57 am

Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around?

Motley Fool

Tue, 04/25/17 - 11:10 am

Valeant Pharmaceuticals

AstraZeneca moving costs rise as new HQ nears completion

Yahoo/Reuters

Tue, 04/25/17 - 11:06 am

FDA explains why it rejected AstraZeneca's ZS-9

BioPharma Dive

Fri, 04/21/17 - 11:27 am

AstraZeneca Seroquel whistleblower suit diminished but preserved by federal judge

Fierce Pharma

Thu, 04/20/17 - 09:52 am

whistleblower lawsuits

Pages